Published in Neuroscience on January 01, 1981
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus (2000) 2.18
High-resolution in situ hybridization histochemistry. Methods Enzymol (1989) 2.11
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature (1995) 1.83
Dopaminergic terminals in the rat cortex. Science (1973) 1.73
Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci (1997) 1.66
G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci (1993) 1.66
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci (1997) 1.62
Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J Neurochem (1988) 1.61
Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol (1999) 1.60
Dendritic release of dopamine in the substantia nigra. Nature (1981) 1.58
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Selective activation of mesocortical DA system by stress. Nature (1976) 1.56
High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol (1998) 1.54
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci (1996) 1.51
Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res (1999) 1.48
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport (1994) 1.46
Stimulation of dopamine release by GABA in rat striatal slices. Brain Res (1978) 1.45
Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res (1989) 1.45
Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci (1998) 1.44
Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci (2001) 1.43
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse (2007) 1.41
Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron (1991) 1.40
Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience (1984) 1.39
Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. Mol Pharmacol (1973) 1.36
Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci (1998) 1.36
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J Pharmacol Exp Ther (1968) 1.33
Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res (1989) 1.32
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Anatomical and electrophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res (1987) 1.29
Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res (1984) 1.23
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21
Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature (1984) 1.20
Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci (1997) 1.19
Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience (1988) 1.19
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol (1973) 1.19
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol (1997) 1.18
Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg (2001) 1.17
Catecholaminergic depressant effects on bulbar respiratory mechanisms. Brain Res (1979) 1.16
Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res (1980) 1.16
Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L). J Comp Neurol (1990) 1.16
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res (1976) 1.13
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13
Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem (1998) 1.13
Anatomical and functional evidence for lesion-specific sprouting of corticostriatal input in the adult rat. J Comp Neurol (1996) 1.12
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol (1978) 1.11
Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp Neurol (2000) 1.11
Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol (1997) 1.11
Segregation and convergence of information flow through the cortico-subthalamic pathways. J Neurosci (2001) 1.11
Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature (1980) 1.09
Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats. Exp Neurol (1992) 1.09
Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol (2000) 1.09
Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience (1992) 1.09
Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci (1994) 1.08
Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J Pharmacol Exp Ther (1977) 1.08
Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Eur J Pharmacol (1971) 1.07
Acetylcholine synthesis from (2- 14 C)pyruvate in rat striatal slices. J Neurochem (1973) 1.06
In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci U S A (1979) 1.05
Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine. Eur J Pharmacol (1978) 1.05
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol (1984) 1.04
Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. Pharmacol Rev (1966) 1.04
Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem (1998) 1.04
Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J Comp Neurol (1994) 1.04
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem (1991) 1.04
Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J Neurochem (1999) 1.02
Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci U S A (1969) 1.02
[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. Presse Med (1997) 1.02
Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans (2005) 1.02
The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.02
[Sweet's syndrome associated with squamous cell bronchial carcinoma. Neutrophilic dermatosis and non-small cell lung cancer]. Rev Mal Respir (2007) 1.02
Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur J Neurosci (2001) 1.01
Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem (1995) 1.01
Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J Neurosci (1999) 1.01
Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem Pharmacol (1966) 1.01
Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. Proc Natl Acad Sci U S A (1984) 1.01
Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem (1991) 1.01
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett (1992) 1.00
An abundant mRNA of the embryonic brain persists at a high level in cerebellum, hippocampus and olfactory bulb during adulthood. Eur J Neurosci (1993) 1.00
Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00
Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum. J Neurochem (1971) 1.00
Gap junctional communication and pharmacological heterogeneity in astrocytes cultured from the rat striatum. J Physiol (1998) 0.99
[Pulmonary metastases from Abrikossoff's tumour. Transformation capability of a benign granular cell tumour]. Rev Mal Respir (2007) 0.99
Cortical lesions induce an increase in cell number and PSA-NCAM expression in the subventricular zone of adult rats. J Comp Neurol (1996) 0.98